| |
| |
|
| Insider
Information: |
High Susanna Gatti |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
162,542 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,026,552 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
162,542 |
|
|
| Total
Value |
$5,026,552 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bluebird Bio, Inc. |
BLUE |
Chief Operating Officer |
2018-12-06 |
13,750 |
2016-12-01 |
0 |
Premium* |
|
|
Dyne Therapeutics, Inc. |
DYN |
|
2024-06-12 |
148,792 |
2020-09-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DYN |
Dyne Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-11-02 |
4 |
AS |
$7.40 |
$73,549 |
D/D |
(9,939) |
94,605 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
94,893 |
189,498 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2023-12-11 |
4 |
AS |
$10.72 |
$17,324 |
D/D |
(1,616) |
187,882 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2024-03-07 |
4 |
AS |
$25.85 |
$41,127 |
D/D |
(1,591) |
186,291 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2024-03-08 |
4 |
AS |
$26.66 |
$725,344 |
D/D |
(27,199) |
159,092 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2024-03-11 |
4 |
AS |
$25.70 |
$58,904 |
D/D |
(2,292) |
156,800 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2024-05-16 |
4 |
AS |
$28.20 |
$77,402 |
D/D |
(2,738) |
154,062 |
0 |
% |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2024-06-10 |
4 |
OE |
$5.54 |
$443,200 |
D/D |
80,000 |
234,062 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2024-06-10 |
4 |
AS |
$30.24 |
$2,419,200 |
D/D |
(80,000) |
154,062 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2024-06-11 |
4 |
AS |
$31.23 |
$164,582 |
D/D |
(5,270) |
148,792 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2024-06-12 |
4 |
OE |
$5.54 |
$221,600 |
D/D |
40,000 |
188,792 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
Chief Operating Officer |
• – – |
2024-06-12 |
4 |
AS |
$33.17 |
$1,334,201 |
D/D |
(40,000) |
148,792 |
0 |
- |
|
37 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
